People · Operator

Gabby Contro

Named in public records as an officer, director or promoter · active 2020–2025 · Healthtech, Other, Other Technology

4
Companies
7
Filings
$110.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Flume Health, Inc.HealthtechSeries B$35.9M$446.0M2022
PowerToFly Inc.OtherSeries B$33.5M$279.8M2022
UserEvidence, Inc.Other TechnologySeries A$20.9M$26.9M2020
Catch Financial, Inc.Other TechnologySeries A$19.6M$222.4M2021
Operator network

Gabby Contro at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Cedric Kovacs-Johnson · 1 companies · 1 sharedCedric Kovacs-Joh…Jon Sklaroff · 1 companies · 1 sharedJon SklaroffEric Chin · 17 companies · 1 sharedEric ChinKatharine Zaleski · 1 companies · 1 sharedKatharine ZaleskiMilena Berry · 1 companies · 1 sharedMilena BerryNick Nocito · 1 companies · 1 sharedNick NocitoEvan Huck · 1 companies · 1 sharedEvan HuckRaymond Rhodes · 1 companies · 1 sharedRaymond RhodesAndrew Ambrosino · 1 companies · 1 sharedAndrew AmbrosinoKristen Anderson · 1 companies · 1 sharedKristen AndersonKristen Tyrrell · 1 companies · 1 sharedKristen TyrrellFlume Health, Inc. · $35.9M raisedFlume Health, Inc.PowerToFly Inc. · $33.5M raisedPowerToFly Inc.UserEvidence, Inc. · $20.9M raisedUserEvidence, Inc.Catch Financial, Inc. · $19.6M raisedCatch Financial, Inc.Gabby ControGC
Gabby Contro Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Gabby Contro on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Eric Chin117
Milena Berry11
Katharine Zaleski11
Evan Huck11
Raymond Rhodes11
Nick Nocito11
Cedric Kovacs-Johnson11
Jon Sklaroff11
Kristen Anderson11
Andrew Ambrosino11
Kristen Tyrrell11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.